Correlation between proliferative diabetic retinopathy in type 2 diabetes and hypertension, dyslipidemia, and diabetic nephropathy


Abstract views: 230 / PDF downloads: 35

Authors

  • Dr. V. H. Karambelkar Professor and Head , Department of Ophthalmology, Krishna Vishwa Vidyapeeth, Karad, Maharashtra, India Author
  • Dr. Gadre Girish A. Associate Professor , Department of Ophthalmology, Krishna Vishwa Vidyapeeth, Karad, Maharashtra, India Author

Keywords:

Fundus Diabetic Retinopathy, Hypertension, Dyslipidemia, Diabetic Nephropathy

Abstract

Diabetics develop chronic, sight-threatening retinopathy. Retinal blood vessel injuries blind. To determine its clinical profile and link to hypertension, dyslipidemia, and nephropathy, all type 2 diabetics have their fundus tested for proliferative diabetic retinopathy. Cross-sectional. Karad's Krishna Hospital offers ophthalmology. 2019–2021. Our OPD requires pre-registration. Proliferative diabetic retinopathy patients also had hypertension, dyslipidemia, and nephropathy examined. Assessed. Proliferative diabetic retinopathy data evaluated hypertension, dyslipidemia, and diabetic nephropathy. 44 people were studied from December 2019–May 2021. Excel data Qualitative percentages were mean +/- SD. (min-max). Matches. Chi-square tests compared qualitative variables. An independent student t test evaluated quantitative data between groups when appropriate. Significant. Analyzed open epi 2.3.1 data. Non-compliant 56-year-olds 9.98. Noncompliance. 70% had abnormal cholesterol. PDR was 98% triglycerides. 66% HDL. Benefit less. HDL/LDL. 62% had hypertension. HTN lasted 5–6 years; PDR began sooner. Surveys should detect diabetes and lower risk factors. Diabetics need early retinopathy screening. Counseling non-adherents minimizes sickness.

References

Gardner TW, Antonetti DA, Barber AJ, LaNoue KF, Levison SW, Penn State Retina Research Group. Diabetic retinopathy: more than meets the eye. Survey of ophthalmology. 2002 Dec 1;47: S253-62.

Jeng CJ, Hsieh YT, Yang CM, Yang CH, Lin CL, Wang IJ. Diabetic retinopathy in patients with diabetic nephropathy: development and progression. PLoS One. 2016 Aug 26;11(8): e0161897.

Sisodia DS, Nair S, Khobragade P. Diabetic retinal fundus images: Preprocessing and feature extraction for early detection of diabetic retinopathy. Biomedical and Pharmacology Journal. 2017 Jun 20;10(2):615-26.

Kamarainen TK, Sorri L, Pietilä AR, Uusitalo HK. the Diaretdb1 diabetic retinopathy database and evaluation protocol. In Proceedings of British Machine Vision Conference 2007 Sep 10 (Vol. 15, No. 10). BMVA Press.

Baek SU, Park MS, Cho BJ, Park IW, Kwon S. Risk factors associated with progression of diabetic retinopathy in eyes treated with panretinal photocoagulation. Scientific Reports. 2021 Jul 5;11(1):1-0.

Nittala MG, Keane PA, Zhang K, Sadda SR. Risk factors for proliferative diabetic retinopathy in a Latino American population. Retina (Philadelphia, Pa.). 2014 Aug;34(8):1594.

Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR, UKPDS Group. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney international. 2003 Jan 1;63(1):225-32.

Additional Files

Published

2023-10-05

Issue

Section

Articles

How to Cite

1.
Correlation between proliferative diabetic retinopathy in type 2 diabetes and hypertension, dyslipidemia, and diabetic nephropathy. International Journal of Medical Research [Internet]. 2023 Oct. 5 [cited 2024 Nov. 23];2(5):1-9. Available from: https://ijmr.online/index.php/ijmr/article/view/33